Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors

J. Svobodová, J. Procházková, M. Kabátková, M. Krkoška, L. Šmerdová, H. Líbalová, J. Topinka, J. Kléma, A. Kozubík, M. Machala, J. Vondráček,

. 2019 ; 172 (2) : 368-384. [pub] 20191201

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

The aryl hydrocarbon receptor (AhR) activation has been shown to alter proliferation, apoptosis, or differentiation of adult rat liver progenitors. Here, we investigated the impact of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated AhR activation on a human model of bipotent liver progenitors, undifferentiated HepaRG cells. We used both intact undifferentiated HepaRG cells, and the cells with silenced Hippo pathway effectors, yes-associated protein 1 (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), which play key role(s) in tissue-specific progenitor cell self-renewal and expansion, such as in liver, cardiac, or respiratory progenitors. TCDD induced cell proliferation in confluent undifferentiated HepaRG cells; however, following YAP, and, in particular, double YAP/TAZ knockdown, TCDD promoted induction of apoptosis. These results suggested that, unlike in mature hepatocytes, or hepatocyte-like cells, activation of the AhR may sensitize undifferentiated HepaRG cells to apoptotic stimuli. Induction of apoptosis in cells with silenced YAP/TAZ was associated with upregulation of death ligand TRAIL, and seemed to involve both extrinsic and mitochondrial apoptosis pathways. Global gene expression analysis further suggested that TCDD significantly altered expression of constituents and/or transcriptional targets of signaling pathways participating in control of expansion or differentiation of liver progenitors, including EGFR, Wnt/β-catenin, or tumor growth factor-β signaling pathways. TCDD significantly upregulated cytosolic proapoptotic protein BMF (Bcl-2 modifying factor) in HepaRG cells, which could be linked with an enhanced sensitivity of TCDD-treated cells to apoptosis. Our results suggest that, in addition to promotion of cell proliferation and alteration of signaling pathways controlling expansion of human adult liver progenitors, AhR ligands may also sensitize human liver progenitor cells to apoptosis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025469
003      
CZ-PrNML
005      
20201222155219.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/toxsci/kfz202 $2 doi
035    __
$a (PubMed)31536130
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Svobodová, Jana $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno 61265, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno 61137, Czech Republic.
245    10
$a 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Disrupts Control of Cell Proliferation and Apoptosis in a Human Model of Adult Liver Progenitors / $c J. Svobodová, J. Procházková, M. Kabátková, M. Krkoška, L. Šmerdová, H. Líbalová, J. Topinka, J. Kléma, A. Kozubík, M. Machala, J. Vondráček,
520    9_
$a The aryl hydrocarbon receptor (AhR) activation has been shown to alter proliferation, apoptosis, or differentiation of adult rat liver progenitors. Here, we investigated the impact of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated AhR activation on a human model of bipotent liver progenitors, undifferentiated HepaRG cells. We used both intact undifferentiated HepaRG cells, and the cells with silenced Hippo pathway effectors, yes-associated protein 1 (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), which play key role(s) in tissue-specific progenitor cell self-renewal and expansion, such as in liver, cardiac, or respiratory progenitors. TCDD induced cell proliferation in confluent undifferentiated HepaRG cells; however, following YAP, and, in particular, double YAP/TAZ knockdown, TCDD promoted induction of apoptosis. These results suggested that, unlike in mature hepatocytes, or hepatocyte-like cells, activation of the AhR may sensitize undifferentiated HepaRG cells to apoptotic stimuli. Induction of apoptosis in cells with silenced YAP/TAZ was associated with upregulation of death ligand TRAIL, and seemed to involve both extrinsic and mitochondrial apoptosis pathways. Global gene expression analysis further suggested that TCDD significantly altered expression of constituents and/or transcriptional targets of signaling pathways participating in control of expansion or differentiation of liver progenitors, including EGFR, Wnt/β-catenin, or tumor growth factor-β signaling pathways. TCDD significantly upregulated cytosolic proapoptotic protein BMF (Bcl-2 modifying factor) in HepaRG cells, which could be linked with an enhanced sensitivity of TCDD-treated cells to apoptosis. Our results suggest that, in addition to promotion of cell proliferation and alteration of signaling pathways controlling expansion of human adult liver progenitors, AhR ligands may also sensitize human liver progenitor cells to apoptosis.
650    _2
$a adaptorové proteiny signální transdukční $x genetika $7 D048868
650    _2
$a apoptóza $x účinky léků $x genetika $7 D017209
650    _2
$a buněčné linie $7 D002460
650    _2
$a proliferace buněk $x účinky léků $x genetika $7 D049109
650    _2
$a exprese genu $x účinky léků $7 D015870
650    _2
$a lidé $7 D006801
650    _2
$a játra $x účinky léků $x patologie $7 D008099
650    12
$a biologické modely $7 D008954
650    _2
$a polychlorované dibenzodioxiny $x toxicita $7 D000072317
650    _2
$a malá interferující RNA $x genetika $7 D034741
650    _2
$a receptory aromatických uhlovodíků $x metabolismus $7 D018336
650    _2
$a signální transdukce $7 D015398
650    _2
$a kmenové buňky $x účinky léků $x patologie $7 D013234
650    _2
$a trans-aktivátory $x genetika $7 D015534
650    _2
$a transkripční faktory $x genetika $7 D014157
650    _2
$a transfekce $7 D014162
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Procházková, Jiřina $u Department of Chemistry and Toxicology, Veterinary Research Institute, Brno 62100, Czech Republic.
700    1_
$a Kabátková, Markéta $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno 61265, Czech Republic.
700    1_
$a Krkoška, Martin $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno 61265, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno 61137, Czech Republic.
700    1_
$a Šmerdová, Lenka $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno 61265, Czech Republic.
700    1_
$a Líbalová, Helena $u Department of Genetic Ecotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague 14220, Czech Republic.
700    1_
$a Topinka, Jan $u Department of Genetic Ecotoxicology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague 14220, Czech Republic.
700    1_
$a Kléma, Jiří $u Department of Computer Science, Czech Technical University, Prague 12135, Czech Republic.
700    1_
$a Kozubík, Alois $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno 61265, Czech Republic.
700    1_
$a Machala, Miroslav $u Department of Chemistry and Toxicology, Veterinary Research Institute, Brno 62100, Czech Republic.
700    1_
$a Vondráček, Jan $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno 61265, Czech Republic.
773    0_
$w MED00007104 $t Toxicological sciences : an official journal of the Society of Toxicology $x 1096-0929 $g Roč. 172, č. 2 (2019), s. 368-384
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31536130 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155215 $b ABA008
999    __
$a ok $b bmc $g 1599614 $s 1116155
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 172 $c 2 $d 368-384 $e 20191201 $i 1096-0929 $m Toxicological sciences $n Toxicol Sci $x MED00007104
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...